Related by context. Frequent words. (Click for all words.) 76 placebo controlled randomized 75 blind randomized 75 blind randomized controlled 75 Phase III randomized 75 blinded placebo controlled 72 blind randomized placebo 71 multicenter randomized double 71 multicenter randomized 70 randomized placebo controlled 69 randomized controlled 68 multicentre 67 placebo controlled clinical 66 blind placebo controlled 66 multicenter 66 prospective randomized 65 placebo controlled 65 active comparator 64 prospective observational 64 prospective randomized controlled 64 multicenter clinical 64 Phase 1b clinical 63 double blinded placebo 63 label multicenter 63 randomized double 62 randomized #:# 62 double blind placebo 62 label dose escalation 61 dose escalation trial 61 phase IIa 61 nab paclitaxel 61 randomized Phase III 61 Randomized 60 randomized controlled clinical 59 phase IIb 59 single ascending dose 59 PRECiSE 59 dose escalation study 59 randomized clinical 59 Pivotal Trial 59 Phase 2b study 59 Phase Ib 58 randomized 58 Phase III Clinical Trial 58 placebo controlled studies 58 relapsed refractory multiple myeloma 58 Pivotal Phase III 58 Phase 1b trial 58 Phase 2a clinical 58 Phase IIa trial 57 Pivotal Phase 57 pivotal Phase III 57 confirmatory Phase III 57 placebo controlled trials 57 Phase III clinical 57 multicenter study 57 substudy 57 phase 2a 56 multiple ascending dose 56 Phase 2a trial 56 Phase 2b trial 56 noninferiority 56 pertuzumab 56 safety tolerability pharmacokinetics 56 Amrubicin 56 Phase III pivotal 56 Phase IIb trial 56 Phase Ia 56 administered subcutaneously 55 achieved statistical significance 55 pivotal Phase 55 axitinib 55 Phase IIb 55 Completes Enrollment 55 plus dexamethasone 55 plus prednisone 55 non inferiority 55 Navelbine 55 dose escalation 55 Phase 1a 55 Phase III 55 plus gemcitabine 55 mg BID 55 TRITON TIMI 55 Cloretazine R VNP#M 54 Phase IIb clinical 54 randomized Phase 54 Phase 2b clinical 54 relapsing remitting multiple sclerosis 54 Phase 2b 54 dose regimens 54 Phase III Trial 54 ocular hypertension 54 Phase 1b 54 randomized controlled clinical trials 54 Clinical Trial Results 54 Gynecologic Oncology Group 53 Monotherapy 53 aflibercept 53 Phase IIa 53 SPIRIT III 53 randomized clinical trials